Optimizing heart failure management: impact of quadruple therapy initiation at discharge following decompensation events in patients with reduced ejection fraction

12 May 2024 (13:48 - 15:24)

Organised by:

Video

Sign in for access options

Abstract

Slides

About the speaker

Doctor Catarina Gregorio

Centro Hospitalar Universitário Lisboa Norte, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail

The role of intermittent levosimendan infusions in patients with advanced heart failure: is it enough?

Doctor I. Gomes Campos (Penafiel, PT)

Abstract Slides Video

Presentation thumbnail

Predictors of complete evidence-based treatment implementation at hospital discharge of acute heart failure with reduced LVEF in a real-world population

Doctor S. Ruiz Bustillo (Barcelona, ES)

Abstract Slides Video

Presentation thumbnail

12-Month effect of Tafamidis on the clinical progression of cardiac amyloidosis in a single centre cohort

Doctor R. Carvalheiro (Lisbon, PT)

Abstract Slides Video

Presentation thumbnail

Tolerance and clinical response to SGL2 inhibitors in Fabry disease

Doctor I. Mattig (Berlin, DE)

Abstract Slides Video

Access the full session

Session thumbnail

ePosters in chronic heart failure - pharmacotherapy 3

The Event

Event poster

Heart Failure 2024

12 May 2024 13:48 CET

You may be interested in

Congress Presentation

Real-world impact of early quadruple therapy in HFrEF: a comparative analysis of sequential vs. simultaneous approaches

Congress Presentation

Pre-discharge versus post-discharge initiation of quadruple medical therapy in acute heart failure with reduced ejection fraction: Insights from the MCR-HF Registry

Congress Presentation

Initiation and titration of prognostic drug therapy during hospitalization for acute decompensation of heart failure with reduced ejection fraction

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources